An analysis of 188 cases of testicular tumours is presented. Of the 103 cases of seminoma treated with orchidectomy and irradiation of the retroperitoneal lymph nodes, 15 died of the disease, all but 2 within 2 years after operation. Of the remaining 88 patients 9 were treated for metastases. Since then, all 9 have been well and free from recurrence 4 to 10 years after therapy. Fifty of the 73 patients with testicular carcinoma died, most of them within 2 years. So far 23 patients have survived 4 to 10 years or more after treatment. Retroperitoneal lymph node dissection was performed in 17 patients. In 11 cases no metastases were found, and 6 of these patients are still free of disease 3 to 7 years later. Six patients had positive nodes at operation and 2 of these have no signs of recurrence 4 and 5 years after initial treatment, respectively. In our opinion, seminomas are best treated with orchidectomy followed by irradiation of the retroperitoneal lymph nodes. Testicular carcinomas should have a retroperitoneal lymph node dissection followed by irradiation of this region

This content is only available via PDF.
© 1965 S. Karger AG, Basel
1965
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.